b'"of patients withAnalyzing the immune responsemild-to-moderate disease, severe disease and criticaldisease by mass cytometry allows us to cover the innateand adaptive immune responses simultaneously."Benjamin Terrier, MD, PhDCYTOMETRY " Where I believe mass cytometry Professor of Medicine, Internal Medicine Department of Cochin HospitalCYTOF will have the highest impact is during Phase 1 and Phase 2 vaccine studies in humans by contributing invaluable information to the identification of "immunological correlates of protection.Marcelo Sztein, MDAssociate Director for Basic and Translational Research, Center for Vaccine Development and Global Health University of Maryland School of Medicine5'